Technical analysis of Bausch + Lomb Corporation (BLCO): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Bausch + Lomb Corporation is a leading global eye health company. Its operations are structured across three primary segments: Vision Care/Consumer Health, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health division offers a comprehensive portfolio of contact lenses, encompassing all wearing modalities from daily disposables to frequently replaced options.
Price Performance
| 1 month | +16.89% |
| 3 months | +19.26% |
| Year-to-date | +17.10% |
| 1 year | +33.87% |
| 3 years | +18.41% |
52-Week Range
| 52-week High | $21.36 |
| 52-week Low | $14.44 |
| Avg Volume (90d) | 520K |
Technical Indicators
| SMA 50 | $17.35 |
| SMA 200 | $16.67 |
| Beta | 0.65 |
| 30-day Volatility (annualised) | 51.2% |
| Price vs SMA 50 | +15.3% |
| Price vs SMA 200 | +20.0% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-12 | $17.08 | |
| 2026-01 | $16.70 | -2.2% |
| 2026-02 | $18.30 | +9.6% |
| 2026-03 | $15.90 | -13.1% |
| 2026-04 | $15.90 | +0.0% |
| 2026-05 | $15.65 | -1.6% |
| 2026-06 | $16.56 | +5.8% |
| 2026-07 | $16.91 | +2.1% |
| 2026-08 | $17.48 | +3.4% |
| 2026-09 | $17.00 | -2.7% |
| 2026-10 | $20.00 | +17.6% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2027-02-17 | $0.35 | $1.49B |
| 2026-10-28 | $0.21 | $1.37B |
| 2026-07-29 | $0.15 | $1.37B |
| 2026-04-29 | $0.06 | $1.22B |
| 2026-02-18 | $0.35 | $1.39B |
| 2025-10-29 | $0.16 | $1.38B |
| 2025-07-30 | $0.06 | $1.27B |
Price
| Price | $20.00 (closing price, October 30, 2026) |
| Market Cap | $7.1B |
| Exchange | NYSE |
| Country | CA |
Valuation Ratios
| Price / Book | 1.11 |
| EV / EBITDA | 17.10 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.79 |
| Current Ratio | 1.56 |
| Piotroski F-Score | 3 |
| Altman Z-Score | 0.89 |